ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007

Report Urges NCI To Continue 5 A Day, Expand Funding For Communications.

February 9, 2001

Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says

November 28, 2003

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003